Viva Biotech Holdings Total Liabilities

Latest as of June 2025: €2.98 Billion EUR ≈ $3.48 Billion USD

Viva Biotech Holdings total liabilities. Based on the latest financial reports, Viva Biotech Holdings (VB0) has total liabilities worth €2.98 Billion EUR (≈ $3.48 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Viva Biotech Holdings (VB0) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Viva Biotech Holdings (2016–2024)

Total liabilities of Viva Biotech Holdings from 2016 to 2024. This chart illustrates how Viva Biotech Holdings's total liabilities have evolved over time, based on quarterly financial data.

Viva Biotech Holdings Competitors by Total Liabilities

The table below lists competitors of Viva Biotech Holdings ranked by their total liabilities.

Company	Country	Total Liabilities
Singer Thailand Public Company Limited BK:SINGER	Thailand	฿1.71 Billion
JinGuan Electric Co Ltd SHG:688517	China	CN¥511.86 Million
Aramis SAS PA:ARAMI	France	€382.42 Million
Guangzhou Tech-Long Packing Machine Co Ltd SHE:002209	China	CN¥2.47 Billion
Transcontinental Realty Investors NYSE:TCI	USA	$262.32 Million
Teqnion AB ST:TEQ	Sweden	Skr1.31 Billion
Junhe Pumps Holding Co Ltd SHG:603617	China	CN¥858.20 Million
Seoul Food KO:004410	Korea	₩46.52 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Viva Biotech Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Viva Biotech Holdings asset portfolio.

Liquidity & Leverage Metrics

Viva Biotech Holdings Total Liabilities Ratios Explained

Viva Biotech Holdings total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.76	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Viva Biotech Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Viva Biotech Holdings (2016–2024)

The table below shows the annual total liabilities of Viva Biotech Holdings from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€3.23 Billion ≈ $3.78 Billion	-14.03%
2023-12-31	€3.76 Billion ≈ $4.40 Billion	-12.84%
2022-12-31	€4.32 Billion ≈ $5.05 Billion	+4.47%
2021-12-31	€4.13 Billion ≈ $4.83 Billion	-6.05%
2020-12-31	€4.40 Billion ≈ $5.14 Billion	+3522.38%
2019-12-31	€121.39 Million ≈ $141.92 Million	-56.32%
2018-12-31	€277.90 Million ≈ $324.89 Million	+459.82%
2017-12-31	€49.64 Million ≈ $58.03 Million	+96.06%
2016-12-31	€25.32 Million ≈ $29.60 Million	--

About Viva Biotech Holdings

F:VB0 Germany Biotechnology

Market Cap

$345.53 Million

€295.55 Million EUR

Market Cap Rank

#13977 Global

#1434 in Germany

Share Price

€0.14

Change (1 day)

+0.72%

52-Week Range

€0.12 - €0.29

All Time High

€1.18